Profusa, Inc. (PFSA): Nasdaq/NYSE listing notice — NorthView Acquisition Corp. receives Nasdaq notice for late Q3 filing; faces Dec 20 SPAC deadline

Profusa, Inc.

Received Nasdaq notice for failure to timely file Q3 10-Q (Sept 30, 2024); 60 days to submit compliance plan by Feb 4, 2025.
Company expects to file Q3 10-Q within the 60-day period, which would eliminate need for a formal plan.
Nasdaq rule 5815 amendment requires SPACs to complete business combination within 36 months of IPO effectiveness (Dec 20, 2024) or face immediate delisting.
Company applied to trade on OTCQB if delisted; approval not guaranteed. Delisting would not impact Profusa business combination.
Surviving company will apply to list on Nasdaq upon consummation of the Profusa business combination.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Profusa, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

any is working diligently to complete its Form 10-Q for the period ended September 30, 2024. and expects to file its Form 10-Q within the 60-day period described above, which would eliminate the need for the Company to submit a formal plan to regain compliance. As required under Nasdaq Listing Rule 5810(b), the Company issued a press release on December 11, 2024, announcing that it had received the Notice. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K. 1

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Profusa, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-107982

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.